Atomoxetine

It is used in the production of atomoxetine; Atomoxetine is a norepinephrine reuptake inhibitor prescribed for the treatment of children over 6 years of age and adults with Attention Deficit Hyperactivity Disorder (ADHD). Due to the non-stimulant effect of this drug, unlike Ritalin, its distribution in Iranian pharmacies is subject to the rules of general drugs. Unlike other drugs used to control hyperactivity, this drug takes longer to show its therapeutic effect, and this duration is defined as at least 2 weeks.